New EVoluSIon Study Data Demonstrates Strong Support for the SImmetry® Sacroiliac Joint Fusion System
Retrieved on:
Thursday, March 24, 2022
Patel v Mirza, Wurmlingen, LinkedIn, DO, Randomized controlled trial, Â, NASDAQ, Sacroiliac joint dysfunction, Veni, vidi, vici, Marketing, Diagnosis, Sacroiliac joint pain, Conservative management, VAS, Disability, SIJ, De Palma, Fusion, Canadian International Council, Standard of care, Sacroiliac joint, SI, Pain, Article 13, International Society, Twitter, INT, Surgery for the dysfunctional sacroiliac joint, ODI, NASS, North American Spine Society, MCID, GLOBE, Physician, Assessment, Solution, EVSI, Pathology, Patient, Medicine, Pharmaceutical industry, Medical imaging, Silviculture, Spine
Published in the February 2022 issue of the International Journal of Spine Surgery, Clinical Outcomes Following Minimally Invasive Sacroiliac Joint Fusion with Decortication: The EVoluSIon Clinical Study1, reports 12-month clinical outcomes following minimally invasive SIJ fusion using the SImmetry Sacroiliac Joint Fusion system to treat SIJ dysfunction.
Key Points:
- Published in the February 2022 issue of the International Journal of Spine Surgery, Clinical Outcomes Following Minimally Invasive Sacroiliac Joint Fusion with Decortication: The EVoluSIon Clinical Study1, reports 12-month clinical outcomes following minimally invasive SIJ fusion using the SImmetry Sacroiliac Joint Fusion system to treat SIJ dysfunction.
- The SImmetry system is a minimally invasive SI joint fusion system that uses proven orthopedic principles, including joint decortication, bone grafting and fixation, to achieve true arthrodesis.
- The ultimate goal of SI joint fusion is to stabilize the sacroiliac joint to relieve pain due to joint disruption and degeneration.
- Two-Year Outcomes from a Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion vs. Non-Surgical Management for Sacroiliac Joint Dysfunction.